GLA-240 II
Natural health product licensed in Canada
- Other names
- Borage 1000, GLA-240, GLA-240 Vegan, Vegan GLA-240
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80061784
- Status
- Active licence
- Licence date
- 11 June 2015
- Revision date
- 27 November 2022
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Borago officinalis Source : Graine(s) Potency : 240 milligramme gamma-Linolenic acid | 1,091 milligramme | Not calculated |
Non-medicinal ingredients
Huile de carthame, Laurate de saccharose, Carraghénine, Cire d'abeille, Lécithine partiellement hydrolysées, Béhénate de glycéryle, Huile de lin, Glycérine, Amidon de maïs, Sorbitol, Eau, Tocophérols, Dioxyde de silicium, NA, Poly(sorbate) 20, Esters d'acide gras de saccharose, Fécule de pomme de terre, Lécithine, Esters d'acide gras de poly(glycérol), Chlorophylle, Stéaryl fumarate de sodium, Isolat de protein de pois, Huile de tournesol, Hypromellose, Mono- et di- glycérides, Gélatine, Sodium complexe de cuivre chlorophylline, Caramel, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of gamma-linoleic acid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061784
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging